Spyre Therapeutics is based in Cambridge, MA. It has raised $644M in total funding. Latest round: Growth.
Spyre Therapeutics is based in Cambridge, MA. Spyre Therapeutics has raised $644M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in January 2024. The round record for Spyre Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Access Biotechnology, Venrock Healthcare Capital Partners, Perceptive Advisors, RTW Investments, Braidwell, Fairmount and 8 others. 14 distinct backers are named across the disclosed rounds.
Every Spyre Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026